Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G. (Q34301892)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q89169980)
(P304) 875-882
(P407) (Q1860)
(P433) 2
(P478) 80
(P577) Sunday, January 1, 2006
(P1433) (Q1251128)
(P1476) "Uracil DNA glycosylase is dispensable for human immunodeficiency virus type 1 replication and does not contribute to the antiviral effects of the cytidine deaminase Apobec3G." (language: en)
(P2093) Shari M Kaiser
(P2860) (Q24530147)
(Q37746901)
(Q34374847)
(Q37596441)
(Q40522938)
(Q34152408)
(Q40564751)
(Q28179534)
(Q28179446)
(Q28187648)
(Q44194766)
(Q34349275)
(Q34867050)
(Q24303661)
(Q40809319)
(Q40855973)
(Q33911300)
(Q33808996)
(Q33957142)
(Q39549602)
(Q41104028)
(Q24673660)
(Q35866134)
(Q29614384)
(Q43873353)
(Q42034674)
(Q41531689)
(Q45274265)
(Q45236572)
(Q44844586)
(Q44575368)
(Q44238573)
(Q72661436)
(Q71702336)
(Q74672155)
(Q67926108)
other details